Osteopontin expression correlates with adhesive and metastatic potential in metastasis-inducing DNA-transfected rat mammary cell lines
- PMID: 15150606
- PMCID: PMC2409741
- DOI: 10.1038/sj.bjc.6601683
Osteopontin expression correlates with adhesive and metastatic potential in metastasis-inducing DNA-transfected rat mammary cell lines
Abstract
A metastatic phenotype can be induced in benign rat mammary cells (Rama 37 cells) by transfecting them with metastasis-inducing DNAs (Met-DNAs). Stable transfection of Met-DNAs increases the level of the metastasis-associated protein, osteopontin. Randomly picked clonal cell lines have been established from the pool of Rama 37 cells transfected with one metastasis-inducing DNA, C9-Met-DNA. In these cell lines, moderate correlation is observed between the copy number of C9-Met-DNA and their metastatic potential (linear regression coefficient, R(2)=0.48). A very close correlation is observed between the cell lines' metastatic potential in vivo and the osteopontin mRNA levels in vitro (R(2)=0.74), but not with another metastasis-associated protein in this system, S100A4 (R(2)=0.21). A close correlation is also observed between osteopontin mRNA levels and the adhesive potential (R(2)=0.91) of the cells, but not with their growth rate in vitro (R(2)=0.03). These observations support the previous suggestion that osteopontin is the direct effector of C9-Met-DNA and that the presence of C9-Met-DNA is necessary, if not sufficient, for the induction of metastasis in vivo in this system. Additionally, these results suggest that Rama 37 cells with increased osteopontin mRNA levels become metastatic not through an increased growth rate, but through an increase in cellular adhesiveness.
Figures



Similar articles
-
The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model.Oncogene. 1996 Jul 4;13(1):97-104. Oncogene. 1996. PMID: 8700559
-
Metastasis-inducing dna regulates the expression of the osteopontin gene by binding the transcription factor Tcf-4.Cancer Res. 2001 Jul 15;61(14):5619-29. doi: 10.1100/tsw.2002.238. Cancer Res. 2001. PMID: 11454716
-
Isolation of and effector for metastasis-inducing DNAs from a human metastatic carcinoma cell line.Oncogene. 1997 Apr 3;14(13):1581-8. doi: 10.1038/sj.onc.1200993. Oncogene. 1997. PMID: 9129149
-
Use of DNA transfer in the induction of metastasis in experimental mammary systems.Biochem Soc Symp. 1998;63:273-94. Biochem Soc Symp. 1998. PMID: 9513730 Review.
-
Transcriptional regulation of osteopontin and the metastatic phenotype: evidence for a Ras-activated enhancer in the human OPN promoter.Clin Exp Metastasis. 2003;20(1):77-84. doi: 10.1023/a:1022550721404. Clin Exp Metastasis. 2003. PMID: 12650610 Review.
Cited by
-
Metastasis-inducing proteins are widely expressed in human brain metastases and associated with intracranial progression and radiation response.Br J Cancer. 2016 May 10;114(10):1101-8. doi: 10.1038/bjc.2016.103. Epub 2016 Apr 21. Br J Cancer. 2016. PMID: 27100728 Free PMC article.
-
Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients.Br J Cancer. 2006 Apr 10;94(7):1057-65. doi: 10.1038/sj.bjc.6603065. Br J Cancer. 2006. PMID: 16598187 Free PMC article.
-
Host-derived osteopontin maintains an acute inflammatory response to suppress early progression of extrinsic cancer cells.Int J Cancer. 2012 Jul 15;131(2):322-33. doi: 10.1002/ijc.26359. Epub 2011 Oct 20. Int J Cancer. 2012. PMID: 21826648 Free PMC article.
-
The yin and yang of vitamin D receptor (VDR) signaling in neoplastic progression: operational networks and tissue-specific growth control.Biochem Pharmacol. 2010 Jan 1;79(1):1-9. doi: 10.1016/j.bcp.2009.09.005. Epub 2009 Sep 6. Biochem Pharmacol. 2010. PMID: 19737544 Free PMC article. Review.
References
-
- American Cancer Society (1998) Cancer Statistics. CA Cancer J Clin 48: 1–63
-
- Barry ST, Ludbrook SB, Murrison E, Horgan CMT (2000) A regulated interaction between α5β1 integrin and osteopontin. Biochem Biophys Res Commun 267: 764–769 - PubMed
-
- Behrend EI, Craig AM, Wilson SM, Denhardt DT, Chambers AF (1995) Expression of antisense osteopontin RNA in metastatic mouse fibroblasts is associated with reduced malignancy. Ann NY Acad Sci 760: 299–301 - PubMed
-
- Bukholm IK, Nesland JM, Borresen-Dale AL (2000) Re-expression of E-cadherin α′-catenin and β-catenin, but not of γ-catenin, in metastatic tissue from breast cancer patients. J Path 190: 15–19 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous